Atorvastatin Calcium API
9 Inquiries
134523-03-8
Pharmaceutical Grade
99%
Any China Port
25kg/Cardboard Drum
2020-11-20
API,Intermediate
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Atorvastatin calcium
Other Name:1H-Pyrrole-1-heptanoic acid,2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,calcium salt (2:1),(βR,δR)-;1H-Pyrrole-1-heptanoic acid,2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,calcium salt (2:1),[R-(R*,R*)]-;CI 981;Atorvastatin calcium;YM 548;Lipitor;Atorvastatin hemicalcium;Tahor;Sortis;Atorvastatin hemicalcium salt;Storvas;Rotacor;Atocor;Atoraz;Lowlip;Lorvast;334757-04-9;1108202-55-6;1370463-14-1
CAS No.:134523-03-8
Molecular Formula:C33H35FN2O5.1/2Ca
InChIKeys:InChIKey=BWFCZHDTTAYGNN-CNZCJKERSA-N
Molecular Weight:1155.34000
Exact Mass:1154.45000
UNII:C0GEJ5QCSO
DSSTox ID:DTXSID6044303
NCI Thesaurus Code:C78759
HScode:2933990090
Categories:
Characteristics-
PSA:
201.58000
XLogP3:10.10380
Appearance:White Crystalline Powder
Melting Point:176-178ºC
Boiling Point:722.2ºC at 760 mmHg
Flash Point:390.6ºC
Collision Cross Section:231.5 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Hazard IdentificationClassification of the substance or mixture
Skin irritation, Category 2
Eye irritation, Category 2
Specific target organ toxicity â single exposure, Category 3
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Warning
Hazard statement(s) H315 Causes skin irritation
H319 Causes serious eye irritation
H335 May cause respiratory irritation
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
Response P302+P352 IF ON SKIN: Wash with plenty of water/...
P321 Specific treatment (see ... on this label).
P332+P317 If skin irritation occurs: Get medical help.
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P319 Get medical help if you feel unwell.
Storage P403+P233 Store in a well-ventilated place. Keep container tightly closed.
P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
API,Intermediate
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
30
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
About Echemi Pharmaceutical
Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.

Advantage for Pharmaceutical
• Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.
• We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.
• We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.

Product Category
We care for human and animal health and we are committed to creating a better social environment.
• Human API
• Intermediate
• Veterinary API
• Agrochemical
• Fine Chemical
• Custom Synthesis
-
-
Inquiry History9 Inquiries
Country Product Purchase Quantity Date Posted
United Arab Emirates
Atorvastatin Calcium
5 KG Apr 30, 2026
India
Atorvastatin Calcium
1 KG Apr 7, 2026
India
Atorvastatin calcium CEP Grade
1000000.00 G Jun 23, 2026
United Kingdom
Atorvastatin calcium
400 KG Feb 2, 2026
Sri Lanka
Atorvastatin Calcium IP 2022
1000 KG Jun 13, 2026
India
Atorvasatin Calcium IP
300.00 KG Oct 20, 2025
India
Atorvasatin Calcium IP
300.00 KG Oct 17, 2025
India
Atorvastatin calcium
1000 KG Sep 2, 2025
India
Bromocriptine mesylate
100 G May 28, 2026 Post an enquiry for this product
Hot Related Products
-
Manufacturer Supply Low Price Food Grade CAS 62-54-4 Calcium Acetate for Antimycotic Agent$980-1250/MT FOB
-
Food Ingredient Calcium Acetate CAS 62-54-4 Acetic Acid Calcium Salt -
Calcium acetate 99% white powder ZY 62-54-4 zhishang-ZY 62-54-4 -
Calcium acetate2 -
Calcium acetate -
supply Food Ingredient Calcium Acetate CAS 62-54-4 Calcium Salt